We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Polyoxometalate Catalyst Renders Nerve Agents Harmless

By HospiMedica International staff writers
Posted on 30 Apr 2019
A new study describes a polyoxometalate (POM) catalyst that decomposes nerve agents, eliminating their harmful and lethal effects.

Researchers at Brookhaven National Laboratory (BNL; Upton, NY, USA) and Stony Brook University (SBU; NY, USA) conducted a study to investigate the decomposition process of the nerve agent Sarin and its simulant, dimethyl chlorophosphate (DMCP), using a zirconium polytungstate POM. More...
To do so, they used x-ray photoelectron spectroscopy (XPS), a research technique that uses ultrabright x-rays to measure the elemental composition of a sample. They thus observed a change in the charge state of the zirconium atom in the POM molecule.

By comparing diffraction patterns, they found that the disordering of the zirconium-POM crystal lattice resulted in adsorption of the Sarin simulant molecules. Using computer models, they then showed that the resulting structural changes of the POM catalyst exposed zirconium atoms to Sarin, and that these interactions were responsible for the decomposition of DMCP by a tungstate monomerization process that activated nucleophilic hydrolysis. The study was published on April 19, 2019, in the Journal of Physical Chemistry Letters.

“Usually, a catalyst is a rigid structure that remains stable. Initially, this catalyst was a dimer, two big molecules connected by two bridging bonds. It looked like a bicycle with two wheels and a frame connecting them,” said lead author Anatoly Frenkel, PhD, of BNL and SBU. “What we understood after looking at the catalyst is that the bicycle broke into two 'wheels' and the 'frame' was cut. The process of breaking the dimer was equivalent to activating the catalyst.”

“Our work is part of an ongoing, multiagency effort to protect soldiers and civilians from chemical warfare agents,” concluded Dr. Frenkel. “The research requires us to understand molecular interactions on a very small scale, and to develop special characterization methods that are capable of observing those interactions. It is a very complex set of problems that also has a very immediate societal impact.”

Sarin is an extremely toxic synthetic organophosphorus compound generally considered as a weapon of mass destruction. A colorless, odorless liquid, it is an extremely potency nerve agent, with exposure lethal even at very low concentrations, and death occurring within ten minutes of direct inhalation of a lethal dose due to suffocation from lung muscle paralysis. People who absorb a non-lethal dose, but do not receive immediate medical treatment, may suffer permanent neurological damage.

Related Links:
Brookhaven National Laboratory
Stony Brook University


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Fetal Monitor
BT-380
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.